PRESS RELEASE published on 07/17/2025 at 09:00, 11 months 5 days ago Oxurion sécurise le financement de l'acquisition d'Axiodis CRO et projette un closing de l'opération au 1eraoût 2025 Oxurion sécurise le financement et acquiert 72% d'Axiodis CRO, renforçant sa position dans la recherche clinique. Projet d'expansion en Europe. Informations sur www.oxurion.com Acquisition Financement Europe Recherche Clinique Oxurion
BRIEF published on 07/17/2025 at 08:35, 11 months 5 days ago Oxurion Sécurise le Financement pour l'Acquisition d'Axiodis CRO Acquisition Biopharmaceutique Données Cliniques Oxurion Axiodis CRO
BRIEF published on 07/17/2025 at 08:35, 11 months 5 days ago Oxurion Secures Financing for Major Acquisition Acquisition Biopharmaceutical Clinical Data Oxurion Europe Hub
BRIEF published on 07/17/2025 at 08:35, 11 months 5 days ago Oxurion obtient un financement pour une acquisition majeure Acquisition Biopharmaceutique Données Cliniques Oxurion Plateforme Européenne
PRESS RELEASE published on 07/17/2025 at 08:30, 11 months 5 days ago Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025 Oxurion NV secures financing for 72% stake in Axiodis CRO, enhancing its clinical data capabilities. Acquisition aligned with strategic roadmap for European hub. Closing set for August 1, 2025 Acquisition Clinical Data Oxurion NV Axiodis CRO European Hub
PRESS RELEASE published on 07/17/2025 at 08:30, 11 months 5 days ago Oxurion verzekert financiering voor de overname van Axiodis CRO en beoogt een closing op 1 augustus 2025 Oxurion sichert Finanzierung für die Übernahme von Axiodis CRO ab und plant Abschluss der Transaktion am 1. August 2025 Übernahme Finanzierung Oxurion Klinische Daten Therapeutische Entwicklung
BRIEF published on 07/15/2025 at 18:05, 11 months 7 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Shares Transparency Atlas Biopharmaceutical Oxurion
BRIEF published on 07/15/2025 at 18:05, 11 months 7 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actions Atlas Transparence Biopharmaceutique Oxurion
PRESS RELEASE published on 07/15/2025 at 18:00, 11 months 7 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian Transparency legislation Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
PRESS RELEASE published on 07/15/2025 at 18:00, 11 months 7 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV meldt ontvangst van transparantiekennisgeving en verlaagd aandelenposities onder wettelijke drempel. Biofarmaceutisch bedrijf in Leuven actief op gebied van therapeutische innovatie en klinisch onderzoek Transparantiekennisgeving Euronext Brussel Oxurion NV Leuven Biofarmaceutisch
Published on 06/23/2026 at 06:45, 1 hour 41 minutes ago CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds
Published on 06/23/2026 at 06:45, 1 hour 41 minutes ago La confiance des CTO dans le déploiement à grande échelle de l'IA recule pour la troisième année consécutive
Published on 06/23/2026 at 06:01, 2 hours 25 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 01:55, 6 hours 31 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/22/2026 at 23:25, 9 hours 1 minute ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/23/2026 at 08:05, 21 minutes ago Netlight supported selected digital development activities related to BMW Group's Neue Klasse
Published on 06/23/2026 at 08:05, 21 minutes ago ANTHBOT Brings Stadium-Inspired Lawn Care Home with Prime Day Savings on M Series Robot Lawn Mowers
Published on 06/23/2026 at 08:00, 26 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/22/2026 at 18:00, 14 hours 26 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION